Marino Katy A, Little Melissa A, Bursac Zoran, Sullivan Jennifer L, Klesges Robert, Weksler Benny
Department of Surgery, Division of Thoracic Surgery, Center for Population Sciences, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Preventive Medicine, Center for Population Sciences, University of Tennessee Health Science Center, Memphis, Tennessee.
Ann Thorac Surg. 2016 Sep;102(3):911-916. doi: 10.1016/j.athoracsur.2016.03.076. Epub 2016 Jul 27.
Although preoperative smoking is associated with increased postoperative complications in patients who undergo major thoracic surgical procedures, there are no national guidelines that address the patient's preoperative tobacco use. This study examined the typical preoperative management of thoracic surgical patients who are smokers.
The link to an anonymous survey was emailed to cardiothoracic surgeons in the United States. The survey included questions regarding the likelihood of a surgeon to offer surgery and strategies used to assist patients in quitting smoking before surgery.
The majority of the 158 surgeons who responded to the survey were general thoracic surgeons (68%, 107 of 158), in an academic practice (57%, 90 of 158), with more than 15 years of experience (51%, 81 of 158). An overwhelming majority of respondents (98.1%, 155 of 158) considered smoking preoperatively a risk factor for postoperative complications. The most common cessation strategy offered to smokers was pharmacologic intervention (77%, 122 of 158). Nearly half of the surgeons (47%, 74 of 156) would not perform certain operations in a patient who was a current smoker, but only 14% (10 of 74) tested patients preoperatively for smoking. Thoracic surgeons (odds ratio 2.1, p = 0.0379) and surgeons in academic practice (odds ratio 1.9, p = 0.057) were more likely to deny certain surgeries to current smokers. Two thirds of the surgeons (66%, 48 of 74) thought that the ideal wait time from smoking cessation to surgery was 2 to 4 weeks.
There is significant disagreement in the cardiothoracic surgical community regarding how to treat patients who smoke, especially when deciding to deny or postpone surgery. Prospective studies and guidelines are needed.
尽管术前吸烟与接受大型胸外科手术患者术后并发症增加有关,但尚无针对患者术前吸烟情况的国家指南。本研究调查了吸烟的胸外科手术患者的典型术前管理情况。
将匿名调查问卷的链接通过电子邮件发送给美国的心胸外科医生。该调查包括关于外科医生提供手术的可能性以及术前帮助患者戒烟所采用策略的问题。
回复调查的158位外科医生中,大多数是普通胸外科医生(68%,158人中的107人),就职于学术机构(57%,158人中的90人),有超过15年的经验(51%,158人中的81人)。绝大多数受访者(98.1%,158人中的155人)认为术前吸烟是术后并发症的危险因素。向吸烟者提供的最常见戒烟策略是药物干预(77%,158人中的122人)。近一半的外科医生(47%,156人中的74人)不会为当前仍在吸烟的患者进行某些手术,但只有14%(74人中的10人)在术前对患者进行吸烟检测。胸外科医生(优势比2.1,p = 0.0379)和学术机构的外科医生(优势比1.9,p = 0.057)更有可能拒绝为当前吸烟者进行某些手术。三分之二的外科医生(66%,74人中的48人)认为从戒烟到手术的理想等待时间为2至4周。
心胸外科界在如何治疗吸烟患者方面存在重大分歧,尤其是在决定拒绝或推迟手术时。需要进行前瞻性研究并制定指南。